Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

SHOCKING: Kodiak org - What They Never Told You

Why Did Cathie Wood Just Buy 230,000 Shares of Kodiak AI Stock, and Should You?

Kodiak AI gains attention after Cathie Wood’s big buy, but high risk and weak fundamentals make it a speculative bet.

Barchart

3 Self-Driving Car Stocks That Cathie Wood Can’t Get Enough Of

Pony.ai, WeRide, and Kodiak are still loss‑making, yet each is posting double‑digit revenue growth, landing Tier‑1 partnerships, and carrying “Strong Buy” ratings.

Barchart

Cathie Wood Invests Millions in Tempus AI and George Soros-Backed Autonomous Firm After Major Announcement

Cathie Wood's Ark Invest has increased its holdings in Tempus AI and Kodiak AI in recent trades, as these firms accelerate their AI development and collaboration efforts for rapid growth.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Cathie Wood Drops $32 Million On CoreWeave Stock, Buys Bitcoin Dip Via ARKB — Ark Invest Also Picks Shares Of This George Soros-Backed Company

On Monday, Cathie Wood-led Ark Invest executed significant trades, notably acquiring shares in CoreWeave Inc. (NASDAQ:CRWV), ARK 21Shares Bitcoin ETF (BTS: ARKB), Bullish (NYSE:BLSH), and Kodiak AI Inc. (NASDAQ:KDK). These trades reflect Ark’s strategic positioning in emerging technologies and digital assets.

Benzinga

George Soros Is Betting Big on This Self-Driving Car Stock. Should You?

Is Kodiak AI the hidden engine of the self-driving future that George Soros just spotted? Or merely a pit stop?

Barchart

As Robotruck Maker Kodiak Robotics Starts Trading, Should You Buy KDK Stock?

Following the SPAC deal, the company has been renamed to Kodiak AI.

Barchart

George Soros-Backed Kodiak Robotics Merger Funding Announcement Fuels 6% After-Hours Rally In This SPAC Stock

Ares Acquisition Corporation II (NYSE:AACT) shares saw a 6.42% increase during the after-hours session on Tuesday, reaching $9.45. This surge followed the company's successful fundraising for its planned merger with Kodiak Robotics, a company specializing in autonomous vehicle technology.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Jim Cramer: Kodiak Sciences Is A 'Pure Spec' Stock, Recommends Buying This Utilities Stock

On the latest edition of CNBC's “Mad Money Lightning Round,” Jim Cramer called Kodiak Sciences Inc. (NASDAQ:KOD) is a “pure spec” stock.

Benzinga

2 Natural Gas Stocks for Dividend Investors to Grab This October

This article highlights two natural gas stocks offering solid dividend potential, making them attractive picks for income-focused investors this October.

Barchart

Chiefs TE Travis Kelce, Kodiak donate 25,000 hot meals to Kansas City youth

#Chiefs tight end Travis Kelce and Kodiak donated 25,000 hot meals to young people in Kansas City.

USA Today Sports Media Group

Majority of debtors to US hospitals now people with health insurance

Analysts say a ‘sea change’ occurred in the American healthcare system from when only a tenth of debt came from the insured

The Guardian - US

The Ford F-150 Is Now A Testbed For Army Autonomous Driving Tech

The builder selected the F-150 because it had enough room for the computers and its off-road capabilities.

Motor1

The battle to wake up Canberra's nightlife

Four ways Canberra can recharge its nightlife

The Canberra Times

Why Does California Lag In Autonomous Freight Commercialization Testing?

Back in 2012, California adopted legislation, rules of the road so to speak, for the operation of autonomous vehicles on Golden State roadways. It took three more years, until 2015, for implementing regulations to follow.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap of Monday's Biotech Catalysts - End Of the Day Summary

Kodiak Sciences Inc. (NASDAQ:KOD) announced positive topline results its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; tarcocimab) in patients with macular edema due to retinal vein occlusion. Kodiak shares traded in a range of $10.02 to $11.79 on a day volume of 4.05 million shares, closed regular trading session…

RideApart

Recall: 2021-2022 Yamaha Kodiak 700 ATVs Missing Towing Stickers

The United States Consumer Product Safety Commission and Yamaha issue a recall for 2021-2022 Kodiak 700 ATVs missing Maximum Loading Limit stickers.

Benzinga

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase 2b/3 Study

Benzinga

Read Why Barclays Analyst Is 'Negatively Biased' On Kodiak Sciences

Barclays has lowered the firm's price target on Kodiak Sciences Inc (NASDAQ: KOD

Get all your
news in one place.

100's of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.